A miR-centric view of head and neck cancers

Biochimica et Biophysica Acta - Reviews on Cancer

Volumn 1816, Issue 1, 2011, Pages 67-72

  Babu, Janki Mohan ^a   Prathibha, R ^a   Jijith, V S ^a   Hariharan, Ramkumar ^a   Pillai, M Radhakrishna ^a  

^a RAJIV GANDHI CENTRE FOR BIOTECHNOLOGY   (India)

Author keywords

Biomarker; Head and neck squamous cell carcinoma; MicroRNA; Oral cancer

Indexed keywords

MICRORNA;

APOPTOSIS; CARCINOGENESIS; CELL CYCLE REGULATION; DIAGNOSTIC VALUE; DISEASE MARKER; DNA METHYLATION; EPIGENETICS; EPITHELIAL MESENCHYMAL TRANSITION; GENE EXPRESSION; GENE SILENCING; HEAD AND NECK CANCER; HEAD AND NECK CARCINOMA; HUMAN; LEUKOPLAKIA; MOUTH CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; PROMOTER REGION; REVIEW; SENSITIVITY AND SPECIFICITY; SQUAMOUS CELL CARCINOMA;

CARCINOMA; EPIGENESIS, GENETIC; HEAD AND NECK NEOPLASMS; HUMANS; MICRORNAS; NEOPLASMS, SQUAMOUS CELL; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 79955763345     PISSN: 0304419X     EISSN: 0304419X     Source Type: Journal    
DOI: 10.1016/j.bbcan.2011.04.003     Document Type: Review

References (57)

1. Jemal A., Siegel R., Ward E., Hao Y., Xu J., Murray T., Thun M.J. Cancer statistics, 2008. CA Cancer J. Clin. 2008, 58:71-96.
2. Vergeer M.R., Doornaert P.A., Reitveld D.H., Leemans C.R., Slotman B.J., Langendijk J.A. Intensity-modulated radiotherapy reduces radiation-induced morbidity and improves health- related quality of life: results of a non randomized prospective study using a standardized follow-up program. Int. J. Radiat. Oncol. Biol. Phys. 2009, 74:1-8.
3. Smith R.B., Snieze J.C., Weed D.T., Wax M.K. Utilization of free tissue transfer in head and neck surgery, otolaryngol. Head Neck Surg. 2007, 137:182-191.
4. Bourhis J., Lefebvre J.L., Vermorken J.B. Cetuximab in the management of locoregionally advanced head and neck cancer: expanding the treatment options?. Eur. J. Cancer 2010, 46:1979-1989.
5. Hwang H.W., Mendell J.T. MicroRNAs in cell proliferation, cell death, and tumorigenesis. Br. J. Cancer 2006, 94:776-780.
6. Williams A.H., Liu N., van Rooij E., Olson E.N. MicroRNA control of muscle development and disease. Curr. Opin. Cell Biol. 2009, 21:461-469.
7. Carleton M., Cleary M.A., Linsley P.S. MicroRNAs and cell cycle regulation. Cell Cycle 2007, 6:2127-2132.
8. Shah P.P., Hutchinson L.E., Kakar S.S. Emerging role of microRNAs in diagnosis and treatment of various diseases including ovarian cancer. J. Ovarian Res. 2009, 2. 10.1186/1757-2215-2-11.
9. Li M., Marin-Muller C., Bharadwaj U., Chow K.H., Yao Q., Chen C. MicroRNAs: control and loss of control in human physiology and disease. World J. Surg. 2009, 33:667-684.
10. Krutovskikh V.A., Herceg Z. Oncogenic microRNAs (OncomiRs) as a new class of cancer biomarkers. Bioessays 2010, 32:894-904.
11. Lin C.H., Jackson A.L., Guo J., Linsley P.S., Eisenman R.N. Myc-regulated microRNAs attenuate embryonic stem cell differentiation. EMBO J. 2009, 28:3157-3170.
12. Esquela-Kerscher A., Slack F.J. Oncomirs - microRNAs with a role in Cancer. Nat. Rev. Cancer 2006, 6:259-269.
13. Tavazoie S.F., Alarcón C., Oskarsson T., Padua D., Wang Q., Bos P.D., Gerald W.L., Massagué J. Endogenous human microRNAs that suppress breast cancer metastasis. Nature 2008, 451:147-152.
14. Garzon R., Marcucci G., Croce C.M. Targeting microRNAs in cancer: rationale, strategies and challenges. Nat. Rev. Drug Discov. 2010, 9:775-789.
15. Ventura A., Jacks T. MicroRNAs and cancer: short RNAs go a long way. Cell 2009, 136:586-591.
16. Napier S.S., Speight P.M. Natural history of potentially malignant oral lesions and conditions: an overview of the literature. J. Oral Pathol. Med. 2008, 37:1-10.
17. Van der Waal I. Potentially malignant disorders of the oral and oropharyngeal mucosa; terminology, classification and present concepts of management. Oral Oncol. 2009, 45:317-323.
18. Cervigne N.K., Reis P.P., Machado J., Sadikovic B., Bradley G., Galloni N.N., Pintilie M., Jurisica I., Perez-Ordonez B., Gilbert R., Gullane P., Irish J., Kamel-Reid S. Identification of a microRNA signature associated with progression of leukoplakia to oral carcinoma. Hum. Mol. Genet. 2009, 18:4818-4829.
19. Ang K.K., Harris J., Wheeler R., Weber R., Rosenthal D.I., Nguyen-Tân P.F., Westra W.H., Chung C.H., Jordan R.C., Lu C., Kim H., Axelrod R., Silverman C.C., Redmond K.P., Gillison M.L. Human papillomavirus and survival of patients with oropharyngeal cancer. N. Engl. J. Med. 2010, 363:24-35.
20. Childs G., Fazzari M., Kung G., Kawachi N., Brandwein-Gensler M., McLemore M., Chen Q., Burk R.D., Smith R.V., Prystowsky M.B., Belbin T.J., Schlecht N.F. Low-level expression of microRNAs let-7d and miR-205 are prognostic markers of head and neck squamous cell carcinoma. Am. J. Pathol. 2009, 174:736-745.
21. Hui A.B., Lenarduzzi M., Krushel T., Waldron L., Pintilie M., Shi W., Perez-Ordonez B., Jurisica I., O'Sullivan B., Waldron J., Gullane P., Cummings B., Liu F.F. Comprehensive MicroRNA profiling for head and neck squamous cell carcinomas. Clin. Cancer Res. 2010, 16:1129-1139.
22. Avissar M., Christensen B.C., Kelsey K.T., Marsit C.J. MicroRNA expression ratio is predictive of head and neck squamous cell carcinoma. Clin. Cancer Res. 2009, 15:2850-2855.
23. Fletcher A.M., Heaford A.C., Trask D.K. Detection of metastatic head and neck squamous cell carcinoma using the relative expression of tissue-specific mir-205. Transl. Oncol. 2008, 1:202-208.
24. Park N.J., Zhou H., Elashoff D., Henson B.S., Kastratovic D.A., Abemayor E., Wong D.T. Salivary microRNA: discovery, characterization, and clinical utility for oral cancer detection. Clin. Cancer Res. 2009, 15:5473-5477.
25. Wong T.S., Liu X.B., Wong B.Y., Ng R.W., Yuen A.P., Wei W.I. Mature miR-184 as potential oncogenic microRNA of squamous cell carcinoma of tongue. Clin. Cancer Res. 2008, 14:2588-2592.
26. Ivanovska I., Ball A.S., Diaz R.L., Magnus J.F., Kibukawa M., Schelter J.M., Kobayashi S.V., Lim L., Burchard J., Jackson A.L., Linsley P.S., Cleary M.A. MicroRNAs in the miR-106b family regulate p21/CDKN1A and promote cell cycle progression. Mol. Cell. Biol. 2008, 28:2167-2174.
27. Ramdas L., Giri U., Ashorn C.L., Coombes K.R., El-Naggar A., Ang K.K., Story M.D. miRNA expression profiles in head and neck squamous cell carcinoma and adjacent normal tissue. Head Neck 2009, 31:642-654.
28. Visone R., Russo L., Pallante P., De Martino I., Ferraro A., Leone V., Borbone E., Petrocca F., Alder H., Croce C.M., Fusco A. MicroRNAs (miR)-221 and miR-222, both overexpressed in human thyroid papillary carcinomas, regulate p27Kip1 protein levels and cell cycle. Endocr. Relat. Cancer 2007, 14:791-798.
29. Galardi S., Mercatelli N., Giorda E., Massalini S., Frajese G.V., Ciafre S.A., Farace M.G. miR-221 and miR-222 expression affects the proliferation potential of human prostate carcinoma cell lines by targeting p27Kip. J. Biol. Chem. 2007, 282:23716-23724.
30. Mineta H., Miura K., Suzuki I., Takebayashi S., Amano H., Araki K., Harada H., Ichimura K., Wennerberg J.P., Dictor M.R. Low p27 expression correlates with poor prognosis for patients with oral tongue squamous cell carcinoma. Cancer 1999, 85:1011-1017.
31. Queiroz A.B., Focchi G., Dobo C., Gomes T.S., Ribeiro D.A., Oshima C.T. Expression of p27, p21(WAF/Cip1), and p16(INK4a) in normal oral epithelium, oral squamous papilloma, and oral squamous cell carcinoma. Anticancer Res. 2010, 30:2799-2803.
32. Leemans C.R., Braakhuis B.J., Brakenhoff R.H. The molecular biology of head and neck cancer. Nat. Rev. Cancer 2011, 11:9-22.
33. Volinia S., Calin G.A., Liu C.G., Ambs S., Cimmino A., Petrocca F., Visone R., Iorio M., Roldo C., Ferracin M., Prueitt R.L., Yanaihara N., Lanza G., Scarpa A., Vecchione A., Negrini M., Harris C.C., Croce C.M. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:2257-2261.
34. Petrocca F., Vecchione A., Croce C.M. Emerging role of miR-106b-25/miR-17-92 clusters in the control of transforming growth factor beta signalling. Cancer Res. 2008, 68:8191-8194.
35. Zhu S., Si M.L., Wu H., Mo Y.Y. MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1). J. Biol. Chem. 2007, 282:14328-14336.
36. Meng F., Henson R., Wehbe-Janek H., Ghoshal K., Jacob S.T., Patel T. MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 2007, 133:647-658.
37. Frankel L.B., Christoffersen N.R., Jacobsen A., Lindow M., Krogh A., Lund A.H. Programmed cell death 4 (PDCD4) Is an important functional target of the microRNA miR-21 in breast cancer cells. J. Biol. Chem. 2008, 283:1026-1033.
38. Zhu S., Wu H., Wu F., Nie D., Sheng S., Mo Y.Y. MicroRNA-21 targets tumor suppressor genes in invasion and metastasis. Cell Res. 2008, 18:350-359.
39. Lu Z., Liu M., Stribinskis V., Klinge C.M., Ramos K.S., Colburn N.H., Li Y. MicroRNA-21 promotes cell transformation by targeting the programmed cell death 4 genemiR-21 targets PDCD4. Oncogene 2008, 27:4373-4379.
40. Tran N., McLean T., Zhang X., Zhao C.J., Thomson J.M., O'Brien C., Rose B. MicroRNA expression profiles in head and neck cancer cell lines. Biochem. Biophys. Res. Commun. 2007, 358:12-17.
41. Chang S.S., Jiang W.W., Smith I., Poeta L.M., Begum S., Glazer C., Shan S., Westra W., Sidransky D., Califano J.A. MicroRNA alterations in head and neck squamous cell carcinoma. Int. J. Cancer 2008, 123:2791-2797.
42. Chira P., Vareli K., Sainis I., Papandreou C., Briasoulis E. Alterations of microRNAs in solid cancers and their prognostic value. Cancers 2010, 2:1328-1353.
43. Kong W., Yang H., He L., Zhao J.J., Coppola D., Dalton W.S., Cheng J.Q. MicroRNA-155 is regulated by the transforming growth factor beta/Smad pathway and contributes to epithelial cell plasticity by targeting RhoA. Mol. Cell. Biol. 2008, 28:6773-6784.
44. Johnson S.M., Grosshans H., Shingara J., Byrom M., Jarvis R., Cheng A., Labourier E., Reinert K.L., Brown D., Slack F.J. RAS is regulated by the let-7 microRNA family. Cell 2005, 120:635-647.
45. Lee Y.S., Dutta A. The tumor suppressor microRNA let-7 represses the HMGA2 oncogene. Genes Dev. 2007, 21:1025-1030.
46. Henson B.J., Bhattacharjee S., O'Dee D.M., Feingold E., Gollin S.M. Decreased expression of miR-125b and miR-100 in oral cancer cells contributes to malignancy. Genes Chromosomes Cancer 2009, 48:569-582.
47. Scott G.K., Goga A., Bhaumik D., Berger C.E., Sullivan C.S., Benz C.C. Coordinate suppression of ERBB2 and ERBB3 by enforced expression of micro-RNA miR-125a or miR-125b. J. Biol. Chem. 2007, 282:1479-1486.
48. Korpal M., Lee E.S., Hu G., Kang Y. The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2. J. Biol. Chem. 2008, 283:14910-14914.
49. Park S.M., Gaur A.B., Lengyel E., Peter M.E. The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes Dev. 2008, 22:894-907.
50. Ellis A.L., Wang Z., Yu X., Mertz J.E. Either ZEB1 or ZEB2/SIP1 can play a central role in regulating the Epstein-Barr virus latent-lytic switch in a cell-type-specific manner. J. Virol. 2010, 84:6139-6152.
51. Calin G.A., Sevignani C., Dumitru C.D., Hyslop T., Noch E., Yendamuri S., Shimizu M., Rattan S., Bullrich F., Negrini M., Croce C.M. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:2999-3004.
52. Wong T.S., Liu X.B., Ho A.C., Yuen A.P., Ng R.W., Wei W.I. Identification of pyruvate kinase type M2 as potential oncoprotein in squamous cell carcinoma of tongue through microRNA profiling. Int. J. Cancer 2008, 123:251-257.
53. Calin G.A., Croce C.M. MicroRNA-cancer connection: the beginning of a new tale. Cancer Res. 2006, 66:7390-7394.
54. Calin G.A., Croce C.M. Chromosomal rearrangements and microRNAs: a new cancer link with clinical implications. J. Clin. Invest. 2007, 117:2059-2066.
55. Poage G.M., Christensen B.C., Houseman E.A., McClean M.D., Wiencke J.K., Posner M.R., Clark J.R., Nelson H.H., Marsit C.J., Kelsey K.T. Genetic and epigenetic somatic alterations in head and neck squamous cell carcinomas are globally coordinated but not locally targeted. PLoS One 2010, 5:e9651.
56. Kosaki K., Imoto I., Mogi S., Omura K., Inasawa J. Exploration of tumor-suppressive microRNAs silenced by DNA hypermethylation in oral cancer. Cancer Res. 2008, 68:2094-2105.
57. Langevin S.M., Stone R.A., Bunker C.H., Grandis J.R., Sobol R.W., Taioli E. MicroRNA-137 promoter methylation in oral rinses from patients with squamous cell carcinoma of the head and neck is associated with gender and body mass index. Carcinogenesis 2010, 31:864-870.